Agile Therapeutics (AGRX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Agile Therapeutics has finalized a deal to induce cash exercise of existing warrants for purchasing its common stock at a discounted rate of $1.25 per share, expecting to raise about $4.8 million. Closing is slated for February 26, 2024, contingent on standard conditions. The transaction includes the issuance of new warrants, with the potential to buy more shares at $1.00 each, immediately exercisable. H.C. Wainwright & Co. is compensated for facilitating the deal, and the company will file for registration to enable the resale of shares from the new warrants.
For further insights into AGRX stock, check out TipRanks’ Stock Analysis page.